Home
/

Diabetic Ketoacidosis

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 31, 2026
Last updated
May 30, 2026
Key takeaway:

Blood testing for diabetic ketoacidosis (DKA) measures glucose, CO₂ (bicarbonate), sodium, and potassium to detect early signs of glucose excess, acid accumulation, and fluid-electrolyte shifts that threaten vital organs. In DKA, bicarbonate drops below the normal 22–29 mEq/L range as acid load rises, while potassium—normally 3.5–5.0 mEq/L—can fall dangerously during insulin treatment despite appearing normal initially.

Read more →
Table of contents

Diabetic Ketoacidosis and the Markers of a Metabolic Crisis

Diabetic ketoacidosis (DKA) biomarkers are blood signals that capture the body’s switch from sugar use to fat burning when insulin is insufficient. Testing shows three things at once: the fuel in circulation, the acids produced, and the water-and-salt balance. Blood sugar (glucose) reflects unused fuel. Ketones made in the liver—especially beta-hydroxybutyrate and acetoacetate—reveal rapid fat breakdown and double as organic acids. The blood’s acidity and buffering status (pH and bicarbonate) show how much acid load the system is carrying, while the charge balance across dissolved particles (anion gap) points to unmeasured acids accumulating in the bloodstream. Mineral salts (electrolytes) such as potassium and sodium track shifts between cells and blood driven by insulin lack and dehydration, and kidney measures (creatinine, urea) signal reduced filtration during fluid losses. Together, these biomarkers map the severity of metabolic stress, explain symptoms like nausea and fast breathing, and let clinicians titrate insulin, fluids, and electrolytes to safely reverse the crisis. In short, they translate the biology of DKA into actionable numbers for rapid, targeted care.

Reading a DKA Panel

Diabetic ketoacidosis (DKA) blood tests reveal how the body is failing to use glucose, switching to fat breakdown and producing acids (ketones) that overwhelm buffering systems. They show the three pillars of the crisis: excess glucose, rising ketones with a falling bicarbonate/CO₂, and fluid–electrolyte shifts (notably sodium and potassium) driven by osmotic diuresis and dehydration. Together, they reflect the stress on brain, heart, kidneys, and lungs as the body tries to compensate.General ranges: fasting glucose about 70–99, CO₂ (bicarbonate) 22–29, sodium 135–145, potassium 3.5–5.0. In health, fasting glucose tends toward the low end, CO₂ sits mid-to-high 20s, sodium around 138–142, and potassium near 4.0–4.5. In DKA, glucose is high, CO₂ drops, the anion gap widens, measured sodium may appear low from hyperglycemia, and potassium can be normal or high despite whole‑body depletion. People feel intense thirst and urination, abdominal pain, nausea, vomiting, deep rapid breathing, fruity breath, fatigue, and confusion. Pregnancy can develop DKA at lower glucose; children can deteriorate faster.When values are low, they tell you about severity and risk. A low CO₂ means metabolic acidosis from ketones; the lower it is, the heavier the acid load and the more pronounced the compensatory breathing. Low sodium often reflects water shifts and diuresis; the lower it falls, the greater the dehydration and neurologic vulnerability. Low potassium signals depleted cardiac and muscle stores, predisposing to weakness and dangerous heart rhythms. Low glucose is uncommon in active DKA but may appear during recovery if acidosis persists while glucose normalizes.Big picture: DKA labs integrate endocrine failure with kidney filtration, lung compensation, and circulatory volume. Tracking glucose, CO₂, sodium, and potassium alongside ketones and the anion gap shows whether insulin biology is restored, acids are clearing, and organs are protected—key to short‑term stabilization and reducing long‑term risks to the brain, heart, and kidneys.

What a DKA Panel Can and Can't Settle

Diabetic Ketoacidosis (DKA) blood testing is essential because it reveals how well your body is managing energy production, acid-base balance, and electrolyte stability—core processes that affect every organ system. At Superpower, we focus on four key biomarkers: Glucose, CO₂ (bicarbonate), Sodium (Na), and Potassium (K). Together, these markers provide a window into the metabolic and physiological disruptions that occur in DKA, which can impact cardiovascular function, brain health, and overall cellular stability.Glucose measures the amount of sugar in your blood, reflecting how effectively your body is using or storing energy. In DKA, glucose levels are typically very high because insulin is either absent or not working properly. CO₂, measured as bicarbonate, indicates the blood’s buffering capacity against acids. In DKA, CO₂ drops as acids (ketones) build up, signaling metabolic acidosis. Sodium and potassium are electrolytes that help regulate fluid balance, nerve signals, and muscle function. In DKA, sodium may appear low due to water shifts, while potassium can be dangerously high or low, depending on the stage and severity of the condition.Stable glucose, CO₂, sodium, and potassium levels are crucial for maintaining healthy metabolism, heart rhythm, and brain function. Disruptions in these markers during DKA reflect a breakdown in the body’s ability to maintain internal balance, or homeostasis, which can quickly become life-threatening if not recognized.Interpretation of these biomarkers can be influenced by factors such as age, pregnancy, acute illness, medications (like diuretics or insulin), and laboratory methods. These variables can shift normal ranges or mask underlying imbalances, so results are always considered in context.

FAQs

It’s a blood panel that shows if your body has shifted into a ketone-driven, acid-producing state from lack of effective insulin. It assesses energy balance (Glucose), acid–base status (CO₂/bicarbonate), and fluid–electrolyte shifts (Sodium/Na, Potassium/K). Superpower tests your blood for Glucose, CO₂, Na, and K. Results indicate how severe the metabolic disturbance is and whether there are risks to the brain, heart, and kidneys.

DKA is a fast-moving metabolic emergency. Testing confirms the pattern—high glucose, low CO₂ (metabolic acidosis), and sodium/potassium shifts—so severity can be understood and complications anticipated. It’s critical if you have diabetes and develop high sugars, illness, vomiting, or rapid breathing. Early measurement reduces risk of cerebral edema, arrhythmias, and kidney injury.

Yes. With Superpower, our team member can organize a blood draw in your home. We collect a small sample, measure Glucose, CO₂, Na, and K, and deliver results quickly so you understand your metabolic and electrolyte status without visiting a clinic.

There’s no fixed schedule. This panel is done when DKA is suspected—typically during acute illness, very high sugars, persistent vomiting, or rapid/deep breathing. People with diabetes may have these labs repeated during treatment to track correction of acidosis and electrolyte shifts. Routine screening without symptoms is not the purpose of this test.

Insulin deficiency, dehydration, and vomiting drive high glucose and low CO₂ (acidosis). Infection, surgery, or stress hormones raise glucose. SGLT2 inhibitors, low‑carb/fasting states, and alcohol can promote ketosis. Kidney dysfunction alters potassium and bicarbonate. Hyperventilation can raise CO₂ slightly; sample delays can falsely lower CO₂. Severe hyperglycemia can make measured sodium appear low (dilutional).

No special preparation is required for DKA assessment. Do not delay testing for fasting if DKA is a concern. For scheduled (non-urgent) metabolic panels, fasting can standardize glucose but is not required for CO₂, sodium, or potassium. Tell the team about medications and supplements that affect fluids or electrolytes.

References

  1. Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009). Hyperglycemic crises in adult patients with diabetes. Diabetes Care, 32(7), 1335-1343. https://doi.org/10.2337/dc09-9032
  2. Umpierrez, G., Davis, G. M., ElSayed, N. A., Fadini, G. P., Galindo, R. J., Hirsch, I. B., Klonoff, D. C., McCoy, R. G., Misra, S., Gabbay, R. A., Bannuru, R. R., & Dhatariya, K. K. (2024). Hyperglycemic crises in adults with diabetes: A consensus report. Diabetes Care, 47(8), 1257-1275. https://doi.org/10.2337/dci24-0032
  3. Dhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E. (2020). Diabetic ketoacidosis. Nature Reviews Disease Primers, 6(1), 40. https://doi.org/10.1038/s41572-020-0165-1
  4. Umpierrez, G., & Korytkowski, M. (2016). Diabetic emergencies—Ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nature Reviews Endocrinology, 12(4), 222-232. https://doi.org/10.1038/nrendo.2016.15
  5. Arora, S., Henderson, S. O., Long, T., & Menchine, M. (2011). Diagnostic accuracy of point-of-care testing for diabetic ketoacidosis at emergency-department triage: β-hydroxybutyrate versus the urine dipstick. Diabetes Care, 34(4), 852-854. https://doi.org/10.2337/dc10-1844

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey